Introduction

Technology licence agreements often involve complex fee structures, particularly concerning up-front instalments. These fees can have significant legal and commercial consequences depending on how the contract is drafted and the intentions of the parties involved. Understanding the implications of these fees is crucial for licensors and licensees alike to manage risk and ensure fair compensation.

Key Legal & Commercial Implications

• Nature of the Licence Fee
  • If the up-front instalment is expressly described as non-refundable (common in technology licences), then the licensee forfeits it even if they abandon the project.
  • If the agreement is silent or ambiguous, courts/arbitrators often look at whether the fee was intended as consideration for granting the licence (access to IP rights) or as a prepayment for future performance.
• Consideration for Rights Already Granted
  • The licence fee is usually the price for the grant of rights (e.g., the right to use patented technology, know-how, or trade secrets). Once those rights are conferred, the payment is earned, regardless of whether the licensee proceeds with commercialization.
  • In this view, the instalment is not tied to project success but to the legal act of granting the licence.
• Risk Allocation
  • Up-front fees shift risk to the licensee: they pay for access, but bear the risk of non-commercialization.
  • Milestone or royalty-based structures shift risk more evenly, since payments depend on actual project progress or sales.
• Termination Clauses
  • If the agreement allows termination by the licensee, the contract should specify whether fees already paid are refundable.
  • Many agreements state that fees paid are non-refundable, but future instalments or royalties cease upon termination.
• Equitable Considerations
  • In some jurisdictions, if the fee is disproportionately high and the project is abandoned early, the licensee might argue unjust enrichment or seek partial refund.
  • However, sophisticated technology licence agreements usually anticipate this and include clear forfeiture language.

Practical Drafting Approaches

• Non-Refundable Up-Front Fee: Common in biotech, pharma, and engineering licences. Ensures licensor is compensated for disclosure of confidential know-how and opportunity cost.
• Refundable/Convertible Fee: Less common, but sometimes used in university-industry collaborations, where instalments may convert into equity or be partially refundable if the project is abandoned before IP is transferred.
• Hybrid: Partially refundable fees tied to specific deliverables (e.g., transfer of data sets, prototypes).

Conclusion

In most technology licence agreements, the instalment is forfeited if the licensee decides not to proceed. The rationale is that the fee compensates the licensor for granting rights and possibly disclosing confidential know-how, regardless of whether the licensee commercializes.

That said, the contract wording is decisive. If you’re drafting or reviewing such an agreement, it’s best to:

• Clearly state whether up-front fees are refundable or not.
• Align payment structure with project risk allocation.
• Consider hybrid models if flexibility is needed.

Disclaimer

This practice note provides general information on technology licence fee structures and legal implications and is not intended as legal advice. Parties should consult qualified legal professionals for advice tailored to their specific circumstances.